Children’s Cold Medicine Recall – Cold medicines for children under the age of 2 are being voluntarily recalled by drug makers (see complete list of recalled medicines below). The recall comes after the U.S. Food and Drug Administration (FDA) at the end of September issued a preliminary recommendation that very young children not be given over-the-counter cough and cold medicines.
The FDA’s investigation had found reports of 54 deaths from 1969 through September 2006. The deaths, most of which involved children under the age of 2, were associated with decongestant medicines made with pseudoephedrine, phenylephrine or ephedrine. Sixty-nine deaths were associated with antihistamine medicines containing diphenhydramine, brompheniramine or chlorpheniramine.
The FDA will be holding meetings on October 18 and 19 to discuss the safety of these medicines for children up to age 6.
Drug makers argue that their cough and cold medicines are generally safe when used as directed. But in some cases parents may not follow guidelines and may administer overdoses, especially to infants.
Below is the list of medicines being voluntarily recalled:
Concentrated Infants’ Tylenol Drops Plus Cold; Concentrated Infants’ Tylenol Drops Plus Cold & Cough; Pediacare Infant Drops Decongestant (PSE); Pediacare Infant Drops Decongestant & Cough (PSE); Pediacare Infant Dropper Decongestant (PE); Pediacare Infant Dropper Long Acting Cough; Pediacare Infant Dropper Decongestant & Cough (PE) products; Dimetapp Decongestant Plus Cough Infant Drops; Dimetapp Decongestant Infant Drops; Little Colds Decongestant Plus Cough; Little Colds Multi-symptom Cold Formula; Robitussin Infant Cough DM Drops; Triaminic Infant & Toddler Thin Strips Decongestant and Triaminic Infant & Toddler Thin Strips Decongestant Plus Cough.
If your child has been harmed by any of the drugs listed above, and you have a question about your legal rights, please call us toll free at 1-877-934-6274. Since 1984, the Law Offices of Eric Weinberg have successfully represented clients that have been injured by pharmaceutical drugs, obtaining recoveries totaling more than $700 million. For more information, please NJ Product Liability Lawyers.
